文献速递中医内科中药与中成药合理使用

中药活性成分作为卵巢癌治疗候选药物的最新研究进展

The latest research progress: Active components of Traditional Chinese medicine as promising candidates for ovarian cancer therapy.
PubMed 文献 · J Ethnopharmacol · 2024-09-07

本文综述了中药活性成分在卵巢癌治疗中的机制与分子通路,检索PubMed、Web of Science、万方及CNKI等数据库。结果表明,中药活性成分通过诱导肿瘤细胞凋亡、抑制增殖与迁移侵袭、诱导自噬、促进上皮-间质转化及增强放化疗疗效等途径抑制卵巢癌发生发展,但尚需进一步临床研究支持其应用。

要点

  • 中药活性成分可通过多途径抑制卵巢癌发生发展。
  • 中药与放化疗联用可能增强疗效并减轻毒性。
  • 现有证据多来自实验研究,临床转化需进一步验证。

核心结论

  • 中药活性成分可抑制卵巢癌的发生与发展,但其应用仍需进一步临床研究支持。

研究设计与样本

  • 本文为综述,检索PubMed、Web of Science、万方数据库及中国知网(CNKI)中关于中药活性成分预防卵巢癌的相关研究。

主要发现

  • 中药活性成分通过诱导肿瘤细胞凋亡、抑制肿瘤细胞增殖、抑制肿瘤细胞迁移与侵袭、诱导肿瘤细胞自噬、促进上皮-间质转化及增强放化疗药物疗效等机制抑制卵巢癌发生发展。

临床怎么用

  • 中药活性成分可与放化疗药物协同增强治疗效果,为卵巢癌患者提供综合治疗选择。

局限性

  • 中药活性成分的应用仍需进一步临床研究支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Ovarian cancer ranks the first in the mortality of gynecological tumors. Because there are no obvious symptoms in the early stage of ovarian cancer, most patients are in the advanced stage of the disease at the time of diagnosis. The incidence of ovarian cancer is increasing year by year, and the incidence of ovarian cancer has a trend of younger age. In recent years. Traditional Chinese medicine (TCM) has a significant impact on improving the quality of life of cancer patients, reducing drug toxicity, preventing metastasis and recurrence, enhancing the efficacy of radiotherapy and chemotherapy, and prolonging survival time, so patients have benefited a lot. AIM OF THE STUDY: This review summarizes the mechanisms and molecular pathways through which active ingredients of TCM act in ovarian cancer. It explores the advantages of TCM in treating ovarian cancer. This review provides theoretical support for the use of TCM in the treatment of ovarian cancer, offering new perspectives for its clinical prevention and treatment. MATERIALS AND METHODS: This review conducted a literature search on PubMed, Web of Science, Wanfang Database, and China National Knowledge Infrastructure (CNKI) for relevant studies on TCM active ingredients in preventing ovarian cancer. The search terms included "ovarian cancer" combined with "Chinese herbal medicine," "Herbal medicine," "Traditional Chinese medicine," and "Active ingredients of Chinese medicine". Based on existing experimental and clinical research, the paper systematically summarized and analyzed the mechanisms of TCM in treating ovarian cancer. RESULTS: Active ingredients of TCM inhibit the occurrence and development of ovarian cancer through inducing tumor cell apoptosis, inhibiting tumor cell proliferation, suppressing tumor cell migration and invasion, inducing tumor cell autophagy, promoting epithelial-mesenchymal transition, and enhancing the efficacy of radiotherapy and chemotherapy drugs. Chinese medicine provides a comprehensive treatment option for ovarian cancer patients, synergizing with radiotherapy and chemotherapy drugs to enhance treatment effectiveness and introduce new hope and possibilities in clinical therapy. CONCLUSIONS: Active ingredients of TCM can inhibit the occurrence and development of ovarian cancer, but further clinical research is needed to support their application.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang X, Wei X, Shi L, et al. The latest research progress: Active components of Traditional Chinese medicine as promising candidates for ovarian cancer therapy. J Ethnopharmacol. 2024. PMID: 39251149. doi:10.1016/j.jep.2024.118811

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。